Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neutrophil reactive oxygen species (ROS) release refers to the process by which neutrophils, a type of white blood cell, generate and secrete chemically reactive molecules derived from oxygen. This process is central to the innate immune response, enabling neutrophils to kill invading pathogens and regulate inflammation. Key components include NADPH oxidase 2 (NOX2), myeloperoxidase, and superoxide dismutase. While essential for host defense, excessive or misdirected ROS release can contribute to tissue injury and inflammatory diseases.
Inhibition of NADPH oxidase activity; scavenging of ROS
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neutrophil Reactive Oxygen Species Release (Neutrophil ROS Release).